Weight of evidence: Overall evidence is Low-Moderate: multiple animal studies and a growing number of small clinical trials suggest benefits across gutbrain signaling, social and behavioral domains, gastrointestinal symptoms, and neurophysiological patterns, yet most human studies rely on caregiver-reported outcomes, lack biomarker integration, and seldom control for diet, comorbidities, or baseline microbiome composition
The Mounjaro and Zepbound Instructions for Use recommend taking the pen out of the refrigerator about 30 minutes before injecting
92 In another study on tumor metabolism, Sullivan et al
/ T cells are predominantly expressed in the liver
doi: 10.1002/14651858.CD001301.pub2 224 ArhinSKZhaoYLuXChetryMLuJ
Recently, researchers have identified an added benefit of using GLP-1 agonist drugs - weight loss